Protective Effects of Captopril and Valsartan on Memory Function and Gene Expression of Brain-Derived Neurotrophic Factor (BDNF) in Experimental Model of Alzheimer’s Disease in Rats

سال انتشار: 1394
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 188

فایل این مقاله در 14 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_ZUMS-23-100_003

تاریخ نمایه سازی: 11 اردیبهشت 1400

چکیده مقاله:

Background and Objective: The use of AT۱ and ACE inhibitors, as antihypertensive drugs, improves memory function in the elderly people with hypertension and vulnerable to Alzheimer’s disease (AD). Therefore, the aim of this study was to evaluate effects of oral administration of Captopril and Valsartan on memory function and expression of brain-derived neurotrophic factor (BDNF) in experimental model of AD in rats. Materials and Methods: Forty adult male Wistar rats were assigned to five groups Control, Vehicle, Alzheimer, Captopril and Valsartan treated groups. AD in the Alzheimer and treated groups was induced using bilateral i.c.v. injection of streptozotocin (۳mg/kg) in days one and three. Treated groups received captopril (۵۰mg/kg) and valsartan (۳۰mg/kg) orally for ۲۵days. At the end of the experiment, memory function was tested using T-Maze and gene expression of BDNF was assessed by RT-PCR technique. Finally, histopathological damages were evaluated using H&E and toluidine blue staining methods. Results: Time of latency and error number for food searching was ۷۳.۴±۱۵.۵Sec and ۱۱.۸±۱.۲ in the control group respectively, induction of AD significantly increased these issues (۲۱۶.۲±۵۷.۹Sec, ۱۶.۲±۲.۹). Histopathological damages (necrotic neurons and tissue vacuolization) along with reduction of BDNF mRNA were obviously observed in rats of the Alzheimer group. Captopril and valsartan treatment led to a decrease in the time of latency (۴۶ and ۸۶%) and error number (۳۱ and ۴۳%) and improved histopathological damages and increased BDNF mRNA. Conclusion: Our findings indicated that inhibition of central renin-angiotensin improves memory function and neuronal damages during AD disease. It appears that activation of this system inhibits gene expression of BDNF.

کلیدواژه ها:

Key words: Renin-angiotensin System ، Captopril ، Valsartan ، BDNF ، Alzheimer’s Disease

نویسندگان

یاسمن ارجمند عباسی

Dept. of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran

محمد تقی محمدی

Dept. of Physiology and Biophysics, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran

اکرم عیدی

Dept. of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Reference ...
  • Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseases and oxidative ...
  • Calderon-Garcidenas L, Solt AC, Heriquez-Roldan C. Long-term air pollution exposure ...
  • Fjell AM, Mc-Evoy L, Holland D, Dale AM, Kristine B. ...
  • Larson ME, Lesne SE. Soluble Aβ oligomer production and toxicity. ...
  • Nussbaum JM, Seward ME, Bloom GS. alzheimer disease: a tale ...
  • Savaskan E. The role of the brain renin-angiotensin system in ...
  • Ciobica A, Bild W, Hritcu L, Haulica I. Brain renin-angiotensin ...
  • Horiuchi M, Mogi M, Iwai M. The angiotensin II type ...
  • Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM. Renin-angiotensin system ...
  • Wong J, Higgins M, Halliday G, Garner B. Amyloid beta ...
  • Nagahara AH, Merrill DA, Coppola G, et al. Neuroprotective effects ...
  • Binder DK, Scharfman HE. Brain-derived neurotrophic factor. Growth Factors. 2004 ...
  • Inaba S, Iwai M, Furuno M, et al. Continuous activation ...
  • Fournier A, Oprisiu-Fournier R, Serot JM. Prevention of dementia by ...
  • Wright JW, Harding JW. The brain RAS and alzheimer’s disease. ...
  • Zou K, Maeda T, Watanabe A, et al. Abeta42-to-Abeta40- and ...
  • Iwanami J, Mogi M, Iwai M, Horiuchi M. Inhibition of ...
  • Awasthi H, Kaushal D, Siddiqui HH. Chronic inhibition of central ...
  • Singh B, Sharma B, Jaggi AS, Singh N. Attenuating effect ...
  • Jefferson AL, Cantwell NG, Byerly LK, Morhardt D. Medical student ...
  • Pourrabi SR, Mohajjel-Nayebi A, Hossini SE. Role of testosterone in ...
  • Cruz-Laguna EY, Gámez-Méndez AM, Vargas-Robles H, et al. Renin-angiotensin system ...
  • Bayir Y, Halici Z, Karakus E, et al. Comparing effects ...
  • Abo El-Khair DM, El-Nabawia AF, El-Safti Nooh HZ, El-Mehi EA. ...
  • Raouf Sarshoori J, Asadi MH, Mohammadi MT. Neuroprotective effects of ...
  • Galani R, Weiss I, Cassel JC, Kelche C. Spatial memory, ...
  • Kenan CV, Ezgie I, Yildiz G, Birhan YM, Gurlek A, ...
  • Khalili M, Hamzeh F. Effects of active constituents of on ...
  • Chakrabarty M, Bhat P, Kumari S, et al. Cortico-hippocampal salvage ...
  • Saavedra JM. Angiotensin II AT1 receptor blockers as treatments for ...
  • نمایش کامل مراجع